2018 临床实践指南:青春期后女性癌症患者生育能力保留

2018-01-08 国外肿瘤科相关专家小组(统称) Mol Clin Oncol. 2018 Jan;8(1):153-158.

增加生育能力保留(FP)选项使妇女能够在抗癌治疗后保留生育能力,本文主要面向肿瘤科医生针对青春期后女性癌症患者生育能力保留的相关内容提出指导建议。

中文标题:

2018 临床实践指南:青春期后女性癌症患者生育能力保留

英文标题:

Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.

发布日期:

2018-01-08

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 临床实践指南:青春期后女性癌症患者生育能力保留)] GetToolGuiderByIdResponse(projectId=1, id=fffaa1c001552527, title=2018 临床实践指南:青春期后女性癌症患者生育能力保留, enTitle=Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians., guiderFrom=Mol Clin Oncol. 2018 Jan;8(1):153-158., authorId=null, author=, summary=增加生育能力保留(FP)选项使妇女能够在抗癌治疗后保留生育能力,本文主要面向肿瘤科医生针对青春期后女性癌症患者生育能力保留的相关内容提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jan 08 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>增加生育能力保留(FP)选项使妇女能够在抗癌治疗后保留生育能力,本文主要面向肿瘤科医生针对青春期后女性癌症患者生育能力保留的相关内容提出指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>癌症</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=163361c0015a9824" title="重视癌症患者贫血,早期筛查与治疗铁缺乏——欧洲《成年癌症患者铁缺乏的管理意见书》解读" target=_blank>重视癌症患者贫血,早期筛查与治疗铁缺乏——欧洲《成年癌症患者铁缺乏的管理意见书》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ea47c1c0015395b6" title="北京市癌症疼痛管理规范(2017年版)" target=_blank>北京市癌症疼痛管理规范(2017年版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a87a61c0015305d1" title="NCCN临床实践指南:癌症相关感染的预防和治疗(2018.V1)" target=_blank>NCCN临床实践指南:癌症相关感染的预防和治疗(2018.V1)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=760a71c00152a5f2" title="NCCN临床实践指南:癌症和化疗诱导的贫血(2018.V2)" target=_blank>NCCN临床实践指南:癌症和化疗诱导的贫血(2018.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d6d6e1c0015218be" title="《2017年美国国立综合癌症网络肝胆肿瘤临床实践指南(V2版)》更新要点及临床路径" target=_blank>《2017年美国国立综合癌症网络肝胆肿瘤临床实践指南(V2版)》更新要点及临床路径</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%99%8C%E7%97%87" target=_blank>有关癌症更多指南</a></ul>, tagList=[TagDto(tagId=2813, tagName=癌症患者), TagDto(tagId=69703, tagName=生育能力保留)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5182, appHits=68, showAppHits=0, pcHits=4155, showPcHits=1313, likes=129, shares=1, comments=3, approvalStatus=1, publishedTime=Wed Feb 07 09:26:19 CST 2018, publishedTimeString=2018-01-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 07 09:26:19 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 23:35:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 临床实践指南:青春期后女性癌症患者生育能力保留)])
2018 临床实践指南:青春期后女性癌症患者生育能力保留
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1062000, encodeId=c6541062000e0, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:04:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051916, encodeId=658b10519168a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:52 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285993, encodeId=c89528599349, content=好文章大家共同分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Feb 07 16:21:06 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    非常好的文章,受益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1062000, encodeId=c6541062000e0, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:04:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051916, encodeId=658b10519168a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:52 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285993, encodeId=c89528599349, content=好文章大家共同分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Feb 07 16:21:06 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1062000, encodeId=c6541062000e0, content=非常好的文章,受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 17:04:56 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051916, encodeId=658b10519168a, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 12:07:52 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285993, encodeId=c89528599349, content=好文章大家共同分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Feb 07 16:21:06 CST 2018, time=2018-02-07, status=1, ipAttribution=)]
    2018-02-07 虈亣靌

    好文章大家共同分享

    0